{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T18:45:03Z","timestamp":1743360303886},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9S","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>A successfully developed topical botulinum toxin product would overcome the disadvantages of injectable administration commonly seen with all available botulinum products, including the potential pain, bleeding, and bruising associated with injection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>Identify the disadvantages of injectable administration of botulinum products and advantages of topical administration. Identify previous attempts to develop topical products and review the only topical product candidate (ET-01, abbreviated EMX) under clinical development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>A literature review regarding injectable botulinum products and topical botulinum product candidates and an analysis of data regarding EMX development were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Multiple disadvantages of injectable administration and advantages of topical administration of botulinum toxin were identified. If available, topical botulinum products are expected to expand the clinical use of botulinum toxin. Several previous attempts to develop topical products were identified. EMX has been studied for lateral canthal line treatment in multiple controlled phase 2 clinical trials including over 700 subjects. EMX has demonstrated statistically significant positive results.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>The development of a topical botulinum toxin is appealing because it overcomes multiple disadvantages observed with injectable administration and would likely result in increased clinical use of botulinum toxin. The development of EMX shows promise and merits further study.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000004344","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T23:53:25Z","timestamp":1724889205000},"page":"S64-S69","update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Advances in Topical Botulinum Therapy"],"prefix":"10.1097","volume":"50","author":[{"given":"Jonathan T.","family":"Edelson","sequence":"first","affiliation":[{"name":"Eirion Therapeutics, Inc., Woburn, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"key":"R1-20241006","first-page":"S173","article-title":"A validated grading scale for Crow's feet","volume":"34","author":"Carruthers","year":"2008","journal-title":"Dermatol Surg"},{"key":"R2-20241006","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/srt.12595","article-title":"An objective method to assess the improvements of skin texture roughness after botulinum toxin type a treatment of crow\u2019s feet","volume":"25","author":"Cavallini","year":"2019","journal-title":"Skin Res Technol"},{"key":"R3-20241006","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1097\/DSS.0000000000000852","article-title":"Development and validation of a photonumeric scale for evaluation of facial skin texture","volume":"42","author":"Donofrio","year":"2016","journal-title":"Dermatol Surg"},{"key":"R6-20241006","doi-asserted-by":"crossref","first-page":"NP218","DOI":"10.1093\/asj\/sjab358","article-title":"Facial aesthetic priorities and concerns: a physician and patient perception global survey","volume":"42","author":"Fabi","year":"2022","journal-title":"Aesthet Surg J"},{"key":"R8-20241006","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00403-016-1697-9","article-title":"Hyperhidrosis: an update on prevalence and severity in the United States","volume":"308","author":"Doolittle","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"R10-20241006","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0625.2000.009003165.x","article-title":"The 500 Dalton rule for the skin penetration of chemical compounds and drugs","volume":"9","author":"Bos","year":"2000","journal-title":"Exp Dermatol"},{"key":"R11-20241006","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2174\/1567201816666190201143457","article-title":"Topical and transdermal drug delivery: from simple potions to smart technologies","volume":"16","author":"Benson","year":"2019","journal-title":"Curr Drug Deliv"},{"key":"R14-20241006","first-page":"35","article-title":"Topical botulinum toxin","volume":"3","author":"Collins","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"key":"R20-20241006","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.apsb.2013.12.011","article-title":"Enhanced delivery of hydrophilic peptides in vitro by transdermal microneedle pretreatment","volume":"4","author":"Zhang","year":"2014","journal-title":"Acta Pharm Sin B"},{"key":"R22-20241006","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/jdds.jdds_126_20","article-title":"Microneedling: a means of collagen induction therapy","volume":"25","author":"Nair","year":"2021","journal-title":"J Dermatol Dermatol Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T03:13:57Z","timestamp":1728184437000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":10,"journal-issue":{"issue":"9S","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000004344","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"type":"print","value":"1076-0512"},{"type":"electronic","value":"1524-4725"}],"subject":[],"published":{"date-parts":[[2024,7,24]]}}}